Neostig (Neostigmine Methylsulfate)

Neostigmine Methylsulfate, the active ingredient in Neostig, is a acetylcholinesterase inhibitor presented as a sterile injectable solution for intramuscular, intravenous, and subcutaneous use. It is employed to improve neuromuscular transmission in myasthenia gravis, reverse non‑depolarizing neuromuscular blockade after surgery, and treat postoperative ileus.

GNH USA supplies Neostig as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, including major academic medical centers and regional health systems. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Neostigmine is an acetylcholinesterase inhibitor used to enhance cholinergic transmission at the neuromuscular junction.

- Myasthenia gravis: improves muscle strength by increasing acetylcholine availability at the neuromuscular junction. - Reversal of non‑depolarizing neuromuscular blockade: restores spontaneous breathing and muscle function after surgery. - Post‑operative ileus: stimulates intestinal motility to reduce postoperative